Aim for water, herbal teas, or broth-based soups
Dulaglutides safety profile is consistent with other GLP-1 receptor agonists, with transient nausea being the most frequently reported adverse event (14.6% incidence). Dose escalation from 0.75 to 1.5 mg is recommended after at least four weeks, based on individual glycemic control needs [57]
GLP-1RAs are useful tools for the treatment of T2DM, especially for patients aiming weight loss or to hypoglycaemia
It works alongside GLP-1 to improve how your body handles glucose and stores nutrients, and it seems to amplify the appetite and metabolic effects rather than acting alone

DESIGNED TO BE Reusable for environmental stewardship Ready for the connected world Powerful and flexible platform for pharma Small and easy to use A Reusable Autoinjector with a Disposable Cassette DESIGNED WITH INTELLIGENT, REUSABLE DRIVE UNIT WITH OPTIMAL CONNECTIVITY Powerful motor to drive controlled injection of low- and high-viscosity liquid drugs (1 to 200 cps*) Full dose delivery in 10 seconds (adjustable) Simple sleeve-triggered/push-action operation Visual and audible user feedback Rechargeable with 3-year service life (i.e., up to 3 x 365 uses) Optional built-in Bluetooth low energy (BLE) connectivity SINGLE-USE DISPOSABLE CASSETTE 1 ml and 2.25 ml prefilled syringes (glass or COP) with RNS Standard subcutaneous delivery Needle safety before/after injection Up to 70 percent less CO2e impact than disposable autoinjectors Large inspection window Optional radio frequency identification (RFID) Technical Specifications Data provided for standard models